“Mommy, cancer is not hard.”
– Faris D.
If a 6-year-old can say these profound words, then the search for better treatment requires a paradigm shift as well.
The Faris Foundation’s approach to research is unique in that we have made a transformative investment in establishing the Faris D. Virani Ewing Sarcoma Center, the world’s only comprehensive research center dedicated to Ewing sarcoma, at Texas Children’s Hospital.
We firmly believe that the treatment and breakthrough discoveries that take place at the Faris D. Virani Ewing Sarcoma Center will represent the future of Ewing sarcoma treatment and the best hope for children with this aggressive and elusive malady.
We also support transformative investments in the country’s best and brightest pediatric cancer researchers and physicians who not only develop the most innovative therapies but create new knowledge that will result in future cures. We identify, through a rigorous process, a scholar of excellence whose research is made accessible to the public with close quarterly updates on progress – we believe that to truly invest in impactful research, requires a deep commitment and sustained support. Our first scholar of excellence will be in the field of immunotherapy and sarcomas.
About the Faris D. Virani Ewing Sarcoma Center
The Faris D. Virani Ewing Sarcoma Center at Texas Children’s Cancer Center, (an NCI-designated Comprehensive Cancer Center), was established in 2014 with a little over $1,000 in seed funding from Faris’ personal piggy bank, and is the world’s only comprehensive research center dedicated to Ewing sarcoma. Part of the Solid Tumor Programs at Texas Children’s Cancer Center, the FDV Center is dedicated to advancing the research and treatment of Ewing sarcoma, the second most common bone tumor in children. A global leader in research and clinical care, the Center also hosts a biannual international symposium, undergraduate internship program, youth ambassador program, and is home to world’s only round-the-clock access line for anyone affected by Ewing sarcoma. The Center consists of 14 lab team members, and 8 physicians dedicated to seeing Ewing sarcoma patients.